The Pathology Clinical Committee supports an education program aimed at requesters of TFTs as a way to discourage use in patients taking thyroid replacement therapy. The education program should include consumers. The Pathology Clinical Committee supports the proposal to change fT4 and fT3 testing to be a pathologist-determinable test after an abnormal TSH test result. The Pathology Clinical Committee recommends amendments to item 66719 as follows. Table 6: Current and proposed new item descriptor for item 66719 Current item descriptor Proposed new item descriptor
The Pathology Clinical Committee supports an education program aimed at requesters of TFTs as a way to discourage use in patients taking thyroid replacement therapy. The education program should include consumers. The Pathology Clinical Committee supports the proposal to change fT4 and fT3 testing to be a pathologist-determinable test after an abnormal TSH test result. The Pathology Clinical Committee recommends amendments to item 66719 as follows. Table 6: Current and proposed new item descriptor for item 66719 Current item descriptor Proposed new item descriptor
Report%20from%20the%20Pathology%20Clinical%20Committee%20-%20Endocrine%20Tests%20-%20public%20consultation.docx